(IN BRIEF) Accenture, through its renowned creative agency Droga5, has announced the acquisition of SOKO, a leading Brazilian creative agency known for its innovative and culturally resonant brand storytelling. SOKO’s integration into Droga5 São Paulo aims to strengthen the agency’s … Read the full press release
Posted in Art & Culture, Business, Financial, Government, Industrial, Investment, Ireland, Management, Marketing, News, Technology
Tagged Accenture, acquisition, Brazil, Creative Influence, David Droga, Droga5, Eco Moliterno, Felipe Simi, partnership, SOKO
(PRESS RELEASE) NEW YORK, 20-Aug-2021 — /EuropaWire/ — Accenture (NYSE: ACN), a global professional services company with leading capabilities in digital, cloud and security, has announced the appointment of acclaimed creative icon David Droga, founder and chairman of Droga5, named … Read the full press release
Posted in Business, Ireland, Management, Marketing, Media, News, Technology
Tagged Accenture, Accenture Interactive, AdAge, advertising, Adweek, Amazon, Brian Whipple, CEO, creative chairman, David Droga, Droga5, Julie Sweet, Kimberly Clark, leadership, lululemon
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
